Literature DB >> 12353311

Acute promyelocytic leukemia developing in untreated essential thrombocythemia.

Naoaki Sato1, Tatsuo Furukawa, Masayoshi Masuko, Shigeo Hashimoto, Hidenobu Takahashi, Miyako Baba, Koichi Inano, Noriatsu Suzuki, Ken Toba, Ichiro Fuse, Yoshifusa Aizawa.   

Abstract

We describe a patient with untreated essential thrombocythemia (ET) who developed microgranular variant of acute promyelocytic leukemia, 9 years after the initial diagnosis of ET. He achieved complete remission (CR) but relapsed 11 months later. After achieving the second CR, he received peripheral stem cell transplantation from his HLA complete-matched sibling. Five months after the transplantation, he relapsed again with meningeal infiltration of leukemic cells. In this paper, we review cases of promyelocytic transformation of myeloproliferative diseases (MPD) other than chronic myeloid leukemia (CML). To our knowledge, this is the first case of promyelocytic transformation of Philadelphia chromosome negative untreated ET, in whom both t(15;17) and PML-RAR alpha fusion were proven. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353311     DOI: 10.1002/ajh.10195

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Acute promyelocytic leukemia co-existing with JAK2 V617F positive myeloproliferative neoplasm: a case report.

Authors:  Aleksandra Mamorska-Dyga; Jingjing Wu; Pallavi Khattar; Faisal M H Ronny; Humayun Islam; Karen Seiter; Delong Liu
Journal:  Stem Cell Investig       Date:  2016-03-24

2.  Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome.

Authors:  Theodore P Braun; Julia E Maxson; Anupriya Agarwal; Jennifer Dunlap; Stephen E Spurgeon; Elie Traer
Journal:  Leuk Res Rep       Date:  2014-12-25

Review 3.  Transformation from polycythemia vera to acute promyelocytic leukemia: Case report and literature review.

Authors:  Wen-Wen Li; Xiu-Fang Sui; Shuang Fan; Hong Xu; Cheng-Lei Wang; Fei-Ying Wang; Xiao-Dong Mo
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.